NewCo News: Tube Pharmaceuticals Raises Seed Finance for Tubulysins

The intellectual property surrounding a certain class of cancer molecules has found a new home in Tube Pharmaceuticals GmbH, a Vienna-based start-up, which recently closed a seed funding round of €1 million (US$1.4 million).